Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Human Sperm Cryopreservation as an Alternative to the Decline of Sperm Quality With Aging

8 september 2026 bijgewerkt door: IVI Murcia
This observational study will evaluate whether sperm cryopreservation can help preserve sperm quality and molecular characteristics that may be affected by increasing paternal age. Men aged 18 years and older will provide a semen sample and a blood sample for laboratory analysis. Each semen sample will be divided into fresh, slow-frozen, and vitrified aliquots. The study will compare sperm quality (as assessed by computer-assisted sperm analysis), DNA methylation profiles, DNA fragmentation, sperm telomere length before and after cryopreservation. The effects of age on these parameters will also be assessed. The impact of age on seminal plasma extracellular vesicle composition and blood cell telomere length will also be analysed. The goal is to determine whether sperm cryopreservation may represent a strategy for preserving sperm characteristics associated with younger paternal age.

Studie Overzicht

Gedetailleerde beschrijving

The aging process is associated with declining fertility and increased risks of adverse reproductive and offspring health outcomes. Although the effects of maternal age have been extensively studied, the impact of paternal aging on sperm quality, reproductive outcomes, and molecular characteristics of sperm remains incompletely understood.

The primary objective of this study is to evaluate whether sperm cryopreservation may serve as an alternative to the use of sperm collected at older ages in assisted reproduction treatments. The primary endpoint is the difference in sperm DNA methylation patterns between fresh ejaculated samples and samples subjected to cryopreservation. Cryopreservation will be considered a potentially valid strategy if DNA methylation patterns remain substantially preserved following the cryopreservation process.

At least 45 male participants will be recruited and grouped according to age. Participants will provide one semen sample and a peripheral blood sample. Following routine semen analysis, each semen sample will be divided into three aliquots: fresh, slow-frozen, and vitrified. Cryopreserved aliquots will be stored in liquid nitrogen and subsequently thawed or warmed for analysis.

Standard semen parameters, including volume, concentration, motility, sperm kinetics, and morphology, will be evaluated. Additional analyses will include sperm DNA methylation, DNA fragmentation, telomere length, and characterization of extracellular vesicles and their composition. Identical assessments will be performed on fresh and cryopreserved samples to compare the effects of slow freezing and vitrification.

Secondary objectives include evaluating age-related differences in semen quality and molecular biomarkers, identifying markers associated with biological gamete age, characterizing age-related differences in seminal extracellular vesicles, and exploring associations between sperm molecular characteristics and lifestyle. Participants will also complete validated questionnaires regarding lifestyle and dietary habits.

Studietype

Observationeel

Inschrijving (Geschat)

45

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Ja

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

Adult men aged 18-65 years attending IVI Murcia for semen analysis, fertility assessment, semen donation, or assisted reproduction treatment who meet the study eligibility criteria and provide informed consent. Participants will provide semen and blood samples for laboratory assessment of sperm quality and molecular characteristics before and after cryopreservation.

Beschrijving

Inclusion Criteria:

  • Male participants aged 18 to 65 years
  • Attending IVI Murcia for semen analysis and/or assisted reproduction treatment
  • Able and willing to provide written informed consent
  • Willing to provide a semen sample and a blood sample for research purposes

Exclusion Criteria:

  • Previous diagnosis of azoospermia or severe oligozoospermia (sperm concentration <1 million sperm/mL)
  • Known chromosomal abnormality (abnormal karyotype)
  • Known Y chromosome microdeletion
  • Febrile illness within the previous 3 months
  • Presence of varicocele
  • Current use of vitamin or antioxidant supplements intended to improve semen quality

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

Cohorten en interventies

Groep / Cohort
Men aged 18-39 years
Male participants aged 18-39 years who provide semen and blood samples for laboratory assessment of sperm quality and molecular characteristics. Semen samples are divided into fresh, slow-frozen, and vitrified aliquots for comparative analysis.
Men aged 40-49 years
Male participants aged 40-49 years who provide semen and blood samples for laboratory assessment of sperm quality and molecular characteristics. Semen samples are divided into fresh, slow-frozen, and vitrified aliquots for comparative analysis.
Men aged ≥50 years
Male participants aged 50 years and older who provide semen and blood samples for laboratory assessment of sperm quality and molecular characteristics. Semen samples are divided into fresh, slow-frozen, and vitrified aliquots for comparative analysis.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Sperm DNA methylation profile
Tijdsspanne: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
DNA methylation levels of a predefined nine-gene panel measured by pyrosequencing with duplicate measurements and compared between fresh, slow-frozen, and vitrified sperm samples.
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Sperm concentration
Tijdsspanne: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Sperm concentration (million sperm/mL) measured using computer-assisted sperm analysis (CASA).
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Total sperm motility
Tijdsspanne: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Percentage of motile sperm measured using CASA.
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Progressive sperm motility
Tijdsspanne: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Percentage of progressively motile sperm measured using computer-assisted sperm analysis (CASA).
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Normal sperm morphology
Tijdsspanne: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Percentage of sperm with normal morphology assessed by microscopic evaluation of stained slides according to World Health Organization (WHO) criteria.
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Sperm DNA fragmentation
Tijdsspanne: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
DNA fragmentation measured in fresh, slow-frozen, and vitrified sperm samples.
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Sperm telomere length
Tijdsspanne: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Sperm telomere length measured in fresh, slow-frozen, and vitrified sperm samples.
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Seminal plasma extracellular vesicle composition
Tijdsspanne: Baseline (study semen collection visit).
Characterization of seminal plasma extracellular vesicle composition in fresh semen samples.
Baseline (study semen collection visit).

Andere uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Blood leukocyte telomere length
Tijdsspanne: Baseline (study blood collection visit).
Blood cell telomere length measured to investigate its relationship with participant age and sperm molecular characteristics.
Baseline (study blood collection visit).

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Medewerkers

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

10 juni 2026

Primaire voltooiing (Geschat)

31 maart 2027

Studie voltooiing (Geschat)

30 september 2027

Studieregistratiedata

Eerst ingediend

29 juni 2026

Eerst ingediend dat voldeed aan de QC-criteria

8 september 2026

Eerst geplaatst (Werkelijk)

10 september 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

10 september 2026

Laatste update ingediend die voldeed aan QC-criteria

8 september 2026

Laatst geverifieerd

1 september 2026

Meer informatie

Termen gerelateerd aan deze studie

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • 2303-MUR-046-JM
  • 101120126 (Ander subsidie-/financieringsnummer: European Union Horizon Europe Programme - Marie Skłodowska-Curie Actions Doctoral Network AFRODITA)

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

ONBESLIST

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren